Literature DB >> 26032049

Bioenergetic analysis of human peripheral blood mononuclear cells.

N Jones1, J Piasecka1, A H Bryant1, R H Jones1, D O F Skibinski1, Nigel J Francis1, C A Thornton1.   

Abstract

Leucocytes respond rapidly to pathogenic and other insults, with responses ranging from cytokine production to migration and phagocytosis. These are bioenergetically expensive, and increased glycolytic flux provides adenosine triphosphate (ATP) rapidly to support these essential functions. However, much of this work is from animal studies. To understand more clearly the relative role of glycolysis and oxidative phosphorylation in human leucocytes, especially their utility in a translational research setting, we undertook a study of human peripheral blood mononuclear cells (MNCs) bioenergetics. Glycolysis was essential during lipopolysaccharide (LPS)-mediated interleukin (IL)-1β, IL-6 and tumour necrosis factor (TNF)-α production, as 2-deoxy-D-glucose decreased significantly the output of all three cytokines. After optimizing cell numbers and the concentrations of all activators and inhibitors, oxidative phosphorylation and glycolysis profiles of fresh and cryopreserved/resuscitated MNCs were determined to explore the utility of MNCs for determining the bioenergetics health profile in multiple clinical settings. While the LPS-induced cytokine response did not differ significantly between fresh and resuscitated cells from the same donors, cryopreservation/resuscitation significantly affected mainly some measures of oxidative phosphorylation, but also glycolysis. Bioenergetics analysis of human MNCs provides a quick, effective means to measure the bioenergetics health index of many individuals, but cryopreserved cells are not suitable for such an analysis. The translational utility of this approach was tested by comparing MNCs of pregnant and non-pregnant women to reveal increased bioenergetics health index with pregnancy but significantly reduced basal glycolysis and glycolytic capacity. More detailed analysis of discrete leucocyte populations would be required to understand the relative roles of glycolysis and oxidative phosphorylation during inflammation and other immune responses.
© 2015 British Society for Immunology.

Entities:  

Keywords:  cell activation; cytokines; human; inflammation

Mesh:

Substances:

Year:  2015        PMID: 26032049      PMCID: PMC4578510          DOI: 10.1111/cei.12662

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays.

Authors:  Christian R Kreher; Markus T Dittrich; Robert Guerkov; Bernhard O Boehm; Magdalena Tary-Lehmann
Journal:  J Immunol Methods       Date:  2003-07       Impact factor: 2.303

2.  Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells.

Authors:  Min Wu; Andy Neilson; Amy L Swift; Rebecca Moran; James Tamagnine; Diane Parslow; Suzanne Armistead; Kristie Lemire; Jim Orrell; Jay Teich; Steve Chomicz; David A Ferrick
Journal:  Am J Physiol Cell Physiol       Date:  2006-09-13       Impact factor: 4.249

3.  Mitochondrial oxidative phosphorylation protein levels in peripheral blood mononuclear cells correlate with levels in subcutaneous adipose tissue within samples differing by HIV and lipoatrophy status.

Authors:  Cecilia M Shikuma; Mariana Gerschenson; Dominic Chow; Daniel E Libutti; John H Willis; James Murray; Roderick A Capaldi; Michael Marusich
Journal:  AIDS Res Hum Retroviruses       Date:  2008-10       Impact factor: 2.205

Review 4.  Cytokine-producing B lymphocytes-key regulators of immunity.

Authors:  Frances E Lund
Journal:  Curr Opin Immunol       Date:  2008-04-15       Impact factor: 7.486

5.  Interleukin-12 secretion by peripheral blood mononuclear cells is decreased in normal pregnant subjects and increased in preeclamptic patients.

Authors:  Masatoshi Sakai; Hiroshi Tsuda; Kyoko Tanebe; Yasushi Sasaki; Shigeru Saito
Journal:  Am J Reprod Immunol       Date:  2002-02       Impact factor: 3.886

Review 6.  Lipid metabolism in pregnancy and its consequences in the fetus and newborn.

Authors:  Emilio Herrera
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

7.  The effects of cryopreservation on sperm morphology, motility and mitochondrial function.

Authors:  M O'Connell; N McClure; S E M Lewis
Journal:  Hum Reprod       Date:  2002-03       Impact factor: 6.918

8.  The influence of cryopreservation on cytokine production by human T lymphocytes.

Authors:  S Y Wang; M L Hsu; C H Tzeng; H C Hsu; C K Ho
Journal:  Cryobiology       Date:  1998-08       Impact factor: 2.487

9.  Pregnancy insulin, glucose, and BMI contribute to birth outcomes in nondiabetic mothers.

Authors:  Ken K Ong; Barbro Diderholm; Giuseppina Salzano; Dianne Wingate; Ieuan A Hughes; Jane MacDougall; Carlo L Acerini; David B Dunger
Journal:  Diabetes Care       Date:  2008-08-12       Impact factor: 19.112

10.  Activated lymphocytes as a metabolic model for carcinogenesis.

Authors:  Andrew N Macintyre; Jeffrey C Rathmell
Journal:  Cancer Metab       Date:  2013-01-23
View more
  14 in total

1.  Maternal body mass index is associated with an altered immunological profile at 28 weeks of gestation.

Authors:  April Rees; Oliver Richards; Anastasia Allen-Kormylo; Nicholas Jones; Catherine A Thornton
Journal:  Clin Exp Immunol       Date:  2022-05-13       Impact factor: 4.330

2.  Maternal body mass index is associated with an altered immunological profile at 28 weeks of gestation.

Authors:  April Rees; Oliver Richards; Anastasia Allen-Kormylo; Nicholas Jones; Catherine A Thornton
Journal:  Clin Exp Immunol       Date:  2022-03-19       Impact factor: 5.732

3.  Immunometabolic adaptation and immune plasticity in pregnancy and the bi-directional effects of obesity.

Authors:  April Rees; Oliver Richards; Megan Chambers; Benjamin J Jenkins; James G Cronin; Catherine A Thornton
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

4.  Ex vivo Assessment of Mitochondrial Function in Human Peripheral Blood Mononuclear Cells Using XF Analyzer.

Authors:  Alica Schöller-Mann; Katja Matt; Barbara Hochecker; Jörg Bergemann
Journal:  Bio Protoc       Date:  2021-04-05

Review 5.  Metabolism Is Central to Tolerogenic Dendritic Cell Function.

Authors:  Wen Jing Sim; Patricia Jennifer Ahl; John Edward Connolly
Journal:  Mediators Inflamm       Date:  2016-02-11       Impact factor: 4.711

6.  Metabolic Adaptation of Human CD4+ and CD8+ T-Cells to T-Cell Receptor-Mediated Stimulation.

Authors:  Nicholas Jones; James G Cronin; Garry Dolton; Silvia Panetti; Andrea J Schauenburg; Sarah A E Galloway; Andrew K Sewell; David K Cole; Catherine A Thornton; Nigel J Francis
Journal:  Front Immunol       Date:  2017-11-09       Impact factor: 7.561

7.  Does Altered Cellular Metabolism Underpin the Normal Changes to the Maternal Immune System during Pregnancy?

Authors:  Benjamin J Jenkins; April Rees; Nicholas Jones; Catherine A Thornton
Journal:  Immunometabolism       Date:  2021-10-04

8.  Cellular bioenergetics is impaired in patients with chronic fatigue syndrome.

Authors:  Cara Tomas; Audrey Brown; Victoria Strassheim; Joanna L Elson; Julia Newton; Philip Manning
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

9.  Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells.

Authors:  Amy M Smith; Constanze Depp; Brent J Ryan; Geoffrey I Johnston; Javier Alegre-Abarrategui; Samuel Evetts; Michal Rolinski; Fahd Baig; Claudio Ruffmann; Anna Katharina Simon; Michele T M Hu; Richard Wade-Martins
Journal:  Mov Disord       Date:  2018-10-07       Impact factor: 10.338

10.  Glycolysis gene expression profilings screen for prognostic risk signature of hepatocellular carcinoma.

Authors:  Longyang Jiang; Lan Zhao; Jia Bi; Qiutong Guan; Aoshuang Qi; Qian Wei; Miao He; Minjie Wei; Lin Zhao
Journal:  Aging (Albany NY)       Date:  2019-12-02       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.